Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Neoplasms and STAT1[original query] |
|---|
| Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma. Cancer research 2007 Oct 67 (19): 9561-7. Ruiz-Llorente Sergio, Montero-Conde Cristina, Milne Roger L, Moya Christian M, Cebrián Arancha, Letón Rocío, Cascón Alberto, Mercadillo Fátima, Landa Iñigo, Borrego Salud, Pérez de Nanclares Guiomar, Alvarez-Escolá Cristina, Díaz-Pérez José Angel, Carracedo Angel, Urioste Miguel, González-Neira Anna, Benítez Javier, Santisteban Pilar, Dopazo Joaquín, Ponder Bruce A, Robledo Mercedes, |
| Common variation in genes related to innate immunity and risk of adult glioma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 May 18 (5): 1651-8. Rajaraman Preetha, Brenner Alina V, Butler Mary Ann, Wang Sophia S, Pfeiffer Ruth M, Ruder Avima M, Linet Martha S, Yeager Meredith, Wang Zhaoming, Orr Nick, Fine Howard A, Kwon Deukwoo, Thomas Gilles, Rothman Nathaniel, Inskip Peter D, Chanock Stephen |
| Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma. Oncology 2010 78 (5-6): 382-8. Zhu Zhong-Zheng, Di Jian-Zhong, Gu Wen-Ye, Cong Wen-Ming, Gawron Andrew, Wang Yu, Zheng Qi, Wang Ai-Zhong, Zhu Guanshan, Zhang Pin, Hou Lifa |
| JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Molecular carcinogenesis 2011 Nov . Slattery ML, Lundgreen A, Kadlubar SA, Bondurant KL, Wolff RK |
| Polymorphisms in immune mediators associate with risk of cervical cancer. Gynecologic oncology 2014 Oct 135 (1): 69-73. Zhang Zhengyan, Fye Samantha, Borecki Ingrid B, Rader Janet |
| Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study. Breast cancer research and treatment 2014 Aug 147 (1): 145-58. Slattery Martha L, Lundgreen Abbie, Hines Lisa M, Torres-Mejia Gabriela, Wolff Roger K, Stern Mariana C, John Esther |
| Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer. Cell & bioscience 2015 5 53. Zhang Jialing, Yan Bin, Späth Stephan Stanislaw, Qun Hu, Cornelius Shaleeka, Guan Daogang, Shao Jiaofang, Hagiwara Koichi, Van Waes Carter, Chen Zhong, Su Xiulan, Bi Yong |
| Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell biology and toxicology 2016 Jun . Bao Lianmin, Zhang Yong, Wang Jian, Wang Haiyun, Dong Nian, Su Xiaoqiong, Xu Menglin, Wang Xiangdo |
| FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin. Scientific reports 2016 Jan 6 19229. Wang Shizhi, Wu Shenshen, Meng Qingtao, Li Xiaobo, Zhang Jinchun, Chen Rui, Wang Meil |
| STAT1? enhances STAT1 function by protecting STAT1? from degradation in esophageal squamous cell carcinoma. Cell death & disease 2017 10 8 (10): e3077. Zhang Ying, Chen Yelong, Yun Hailong, Liu Zhaoyong, Su Min, Lai Raymo |
| KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 01 24 (1): 224-233. Lal Neeraj, White Brian S, Goussous Ghaleb, Pickles Oliver, Mason Mike J, Beggs Andrew D, Taniere Philippe, Willcox Benjamin E, Guinney Justin, Middleton Gary |
| Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women. International journal of cancer 2019 May . Kumaran Mahalakshmi, Ghosh Sunita, Joy Anil A, Mackey John R, Cass Carol E, Zheng Wei, Yasui Yutaka, Damaraju Sambasivar |
| IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer. Cancer science 2019 2 110 (4): 1293-1305. Sakahara Mizuho, Okamoto Takuya, Oyanagi Jun, Takano Hiroshi, Natsume Yasuko, Yamanaka Hitomi, Kusama Daisuke, Fusejima Mishio, Tanaka Norio, Mori Seiich, Kawachi Hiroshi, Ueno Masashi, Sakai Yoshiharu, Noda Tetsuo, Nagayama Satoshi, Yao Ryo |
| Interferon-? signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer. NPJ precision oncology 2019 12 3 32. Cardenas Horacio, Jiang Guanglong, Thomes Pepin Jessica, Parker J Brandon, Condello Salvatore, Nephew Kenneth P, Nakshatri Harikrishna, Chakravarti Debabrata, Liu Yunlong, Matei Danie |
| Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer. Clinical breast cancer 2020 4 20 (3): 262-273.e7. Caparica Rafael, Richard François, Brandão Mariana, Awada Ahmad, Sotiriou Christos, de Azambuja Evand |
| Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades. Frontiers in oncology 2021 6 11 650122. Wang Xiaoyan, Wu Bingchen, Yan Zhengqing, Wang Guoqiang, Chen Shiqing, Zeng Jian, Tao Feng, Xu Bichun, Ke Honggang, Li M |
| Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients. Journal of cancer research and clinical oncology 2021 1 147 (3): 725-737. Xin Shuang, Fang Wenfeng, Li Jianwen, Li Delan, Wang Changzheng, Huang Quanfei, Huang Min, Zhuang Wei, Wang Xueding, Chen Lik |
| IL22RA1/JAK/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis. Frontiers in immunology 2022 7 13 915246. Zhang Shuai, Yang Guiy |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: